Can You Take Methylene Blue With Antidepressants?

Do not combine methylene blue with an antidepressant on your own. Methylene blue can inhibit monoamine oxidase A, an enzyme involved in breaking down serotonin. Combining it with medicines that increase serotonergic activity may raise the risk of serotonin syndrome, a potentially serious reaction.

The strongest regulatory warnings come from medical use of intravenous methylene blue. Evidence for lower-dose oral products is more limited—but “limited evidence” does not mean “safe”. If you use an SSRI, SNRI, MAOI or another serotonin-affecting medicine, ask the prescribing clinician or pharmacist before considering any methylene blue product.

Why can methylene blue interact with antidepressants?

Methylene blue has several pharmacological actions. One of the most safety-relevant is reversible inhibition of monoamine oxidase A (MAO-A). When MAO-A is inhibited while a person is taking a serotonergic medicine, serotonin may accumulate.

The US FDA safety communication warns about serious central-nervous-system reactions when methylene blue is given to people taking certain psychiatric medicines. The current prescribing information for intravenous methylene blue carries a boxed warning for serotonin syndrome with serotonergic medicines and opioids.

These official documents concern a prescription intravenous product used for acquired methemoglobinaemia. They should not be used to pretend that every oral supplement dose has been studied in the same way. The FDA has specifically noted that the risk with other routes, including oral use, and with lower intravenous doses was not known from the reported cases. That uncertainty is a reason for caution—not permission to experiment.

Which medicines need particular attention?

Potentially relevant groups include:

• selective serotonin reuptake inhibitors (SSRIs), such as fluoxetine, sertraline, escitalopram and paroxetine;
• serotonin–noradrenaline reuptake inhibitors (SNRIs), such as venlafaxine, desvenlafaxine and duloxetine;
• monoamine oxidase inhibitors (MAOIs);
• some tricyclic antidepressants;
• trazodone, buspirone and other medicines with serotonergic activity;
• some opioids and migraine medicines;
• other supplements or botanicals that may affect serotonin.

This is not a complete interaction list. Brand names differ in South Africa, and combination products can hide relevant ingredients. Give a pharmacist the exact medicine names, doses and the methylene blue label rather than asking only whether “an antidepressant” is safe.

Do not stop an antidepressant to take methylene blue

Stopping an antidepressant suddenly can cause withdrawal symptoms, destabilise mood and create other risks. Washout periods vary because medicines leave the body at different rates; fluoxetine, for example, has a long half-life. A generic “wait a few days” rule is unsafe.

If methylene blue is medically necessary, the treating team should coordinate the plan. If the purpose is optional wellness or self-directed biohacking, the sensible approach is to avoid the combination unless the prescriber explicitly reviews and supports it.

What are the signs of serotonin syndrome?

Symptoms can develop quickly and may include agitation, confusion, sweating, diarrhoea, fever, fast heart rate, tremor, muscle rigidity, overactive reflexes or poor coordination. Severe cases can involve seizures, very high temperature or loss of consciousness.

Seek urgent medical help if concerning symptoms appear after combining serotonin-affecting substances. Do not attempt to manage a suspected severe reaction with supplements or home remedies.

Does the warning apply to capsules as well as liquid?

The interaction concern comes from methylene blue itself, not its blue colour or delivery format. Capsules may reduce taste and staining, while liquids allow different concentration and measuring choices, but neither format removes the pharmacological interaction.

Before buying, read our guide to choosing methylene blue capsules in South Africa and the evidence-focused article Methylene Blue Hype vs Evidence. A certificate of analysis can support identity and purity questions; it cannot prove that an individual drug combination is safe.

Other people who should obtain medical guidance

Professional assessment is particularly important for people with glucose-6-phosphate dehydrogenase (G6PD) deficiency, pregnancy or breastfeeding, significant kidney impairment, complex medication regimens, or a history of serious reactions. The prescription label contraindicates intravenous methylene blue in G6PD deficiency because of haemolytic-anaemia risk.

Frequently asked questions

Can I take methylene blue with sertraline?

Do not combine them without direct prescriber or pharmacist guidance. Sertraline is an SSRI and therefore falls within the interaction concern.

Can I skip my antidepressant on the day I use methylene blue?

No. Skipping one dose does not reliably remove a medicine from the body, and changing treatment without guidance can be harmful.

Is very low-dose oral methylene blue safe with an SSRI?

There is not enough evidence to declare that combination safe. Dose, route, medicine half-life and individual vulnerability all matter.

Does a clean COA rule out serotonin syndrome?

No. A COA may address product specifications or contaminants. It cannot remove an interaction caused by the active molecule.

What should I take to my pharmacist?

Take the full product label, serving amount, ingredient list and a list of every prescription medicine, over-the-counter medicine and supplement you use.

Educational information only. Do not start, stop or change an antidepressant or methylene blue product without appropriate clinical guidance. Suspected serotonin syndrome requires urgent medical assessment.

Written by Lize Bührmann, founder of Pharmatropia.

Further reading and editorial review

Continue with the Methylene Blue South Africa guide and the 16mg vs 25mg vs 100mg capsule comparison.

Author and review: Written and reviewed for responsible product information by Dr Lize Buhrmann, Doctor of Natural Medicine and postgraduate-trained in Phytomedicine.

Evidence standard: General ingredient research is not presented as proof for a specific finished product. Read Pharmatropia’s Editorial & Evidence Policy.